CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Astellas Pharma Inc. v. Zydus Pharmaceuticals (USA) Inc.

1:24-cv-01069

Overview

Case Number 1:24-cv-01069
Filing Date 2024-09-24
Status Litigation filed
Court District Court, D. Delaware (ded)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 35:271 Patent Infringement
Jury Demand Plaintiff

Parties

Defendant

Zydus Lifesciences Limited NPE (University / Research)

Represented By

1 Attorneys Listed

Alexis Stombaugh

Young Conaway Stargatt & Taylor

Tel: +1 (302) 571-6600

Young Conaway Stargatt & Taylor, 1000 North King Street

Zydus Pharmaceuticals (USA) Inc. Operating Company

Represented By

1 Attorneys Listed

Alexis Stombaugh

Young Conaway Stargatt & Taylor

Tel: +1 (302) 571-6600

Young Conaway Stargatt & Taylor, 1000 North King Street

Plaintiff

Astellas Pharma Global Development, Inc. Operating Company

Represented By

5 Attorneys Listed

Michael DelRossi

Email: michael.delrossi@kirkland.com

James F. Hurst

Email: james.hurst@kirkland.com

Diva Hollis

Email: diva.hollis@kirkland.com

Alexandra M. Joyce

McCarter & English, LLP

Tel: +1 (302) 984-6392
Fax: +1 (302) 450-4235

Renaissance Centre, 405 N. King Street, 8th Floor

Daniel M. Silver

McCarter & English, LLP

Tel: +1 (302) 984-6300
Fax: +1 (302) 691-1260

Renaissance Centre, 405 N. King Street, 8th Floor

Astellas Ireland Co., Ltd. Operating Company

Represented By

5 Attorneys Listed

Michael DelRossi

Email: michael.delrossi@kirkland.com

James F. Hurst

Email: james.hurst@kirkland.com

Diva Hollis

Email: diva.hollis@kirkland.com

Alexandra M. Joyce

McCarter & English, LLP

Tel: +1 (302) 984-6392
Fax: +1 (302) 450-4235

Renaissance Centre, 405 N. King Street, 8th Floor

Daniel M. Silver

McCarter & English, LLP

Tel: +1 (302) 984-6300
Fax: +1 (302) 691-1260

Renaissance Centre, 405 N. King Street, 8th Floor

Astellas Pharma Inc. Operating Company

Represented By

5 Attorneys Listed

Michael DelRossi

Email: michael.delrossi@kirkland.com

James F. Hurst

Email: james.hurst@kirkland.com

Diva Hollis

Email: diva.hollis@kirkland.com

Alexandra M. Joyce

McCarter & English, LLP

Tel: +1 (302) 984-6392
Fax: +1 (302) 450-4235

Renaissance Centre, 405 N. King Street, 8th Floor

Daniel M. Silver

McCarter & English, LLP

Tel: +1 (302) 984-6300
Fax: +1 (302) 691-1260

Renaissance Centre, 405 N. King Street, 8th Floor

Court & Judges

Court

District Court, D. Delaware (ded)

Global Patent Family Cross-Litigation Radar

CasLoc 360° Radar 2 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

🇺🇸
U.S. District Courts Counterparts in force
🏛️
USPTO PTAB Trials Counterparts in force
🇪🇺
Unified Patent Court (UPC) Counterparts in force
🇩🇪
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (2): 🇺🇸 US
Parallel Proceedings Across Jurisdictions (0 found):

No active co-pending lawsuits found across other jurisdictions for this family. All related sibling filings are currently unlitigated.

Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Patents Involved

1 Patent

There is a single patent involved in this case.

Patent Asset Filing & Issue Date Expiration & Term Status External Links
US12097189
Pharmaceutical composition for modified release
Filed: 2024-03-22
Issued: 2024-09-24
Active (17.3 yrs remaining)
Expires: 2044-03-22

Patent Enforceability & Injunction Risk Assessment

Statutory Analysis
Injunction Viability (35 U.S.C. § 283) Active Threat

Active Threat — Patent is within enforceable statutory term; injunctive relief viable.

Terminal Disclaimer & Cellect Risk Low Risk

Standard Statutory Term — No obviousness-type double patenting noted.

Damages Lookback Horizon 6-Yr Max Lookback

Under 35 U.S.C. § 286, damages cannot accrue for infringement prior to 6 years before filing. Standard Maintenance Fee Schedule Tracked.

Docket Entries

(20 total)
Pleading / Complaint

COMPLAINT for PATENT INFRINGEMENT filed with Jury Demand against Zydus Lifesciences Limited, Zydus Pharmaceuticals (USA) Inc. ( Filing fee $ 405, receipt number ADEDC-4506216.) - filed by Astellas Pharma Inc., Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc.. (Attachments: # 1 Exhibit A-G, # 2 Civil Cover Sheet)(cdd) (Entered: 09/25/2024)

Entry #1 • 2024-09-24
1

Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (cdd) (Entered: 09/25/2024)

Entry #2 • 2024-09-24
1

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 12,097,189. (cdd) (Entered: 09/25/2024)

Entry #3 • 2024-09-24
1

Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Astellas Pharma Inc., Corporate Parent Astellas B.V. for Astellas Ireland Co., Ltd.; Corporate Parent Astellas Pharma Inc., Corporate Parent Astellas US Holding, Inc. for Astellas Pharma Global Development, Inc. filed by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc.. (cdd) (Entered: 09/25/2024)

Entry #4 • 2024-09-24
1

Summons Issued as to Zydus Lifesciences Limited on 9/24/2024; Zydus Pharmaceuticals (USA) Inc. on 9/24/2024. (Attachments: # 1 Summons Issued)(cdd) (Entered: 09/25/2024)

Entry #5 • 2024-09-24
1

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc